These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1610357)
1. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity. Eugster HP; Bärtsch S; Würgler FE; Sengstag C Biochem Biophys Res Commun; 1992 Jun; 185(2):641-7. PubMed ID: 1610357 [TBL] [Abstract][Full Text] [Related]
2. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae. Wittekindt NE; Würgler FE; Sengstag C DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684 [TBL] [Abstract][Full Text] [Related]
3. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase. Sengstag C; Eugster HP; Würgler FE Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450. Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733 [TBL] [Abstract][Full Text] [Related]
5. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation. Gautier JC; Urban P; Beaune P; Pompon D Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552 [TBL] [Abstract][Full Text] [Related]
6. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants. Shiota N; Kodama S; Inui H; Ohkawa H Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571 [TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA. Yamada T; Imaishi H; Oka A; Ohkawa H Biosci Biotechnol Biochem; 1998 Jul; 62(7):1403-11. PubMed ID: 9720224 [TBL] [Abstract][Full Text] [Related]
8. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Chun YJ; Kim MY; Guengerich FP Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061 [TBL] [Abstract][Full Text] [Related]
10. Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c. Shen AL; Kasper CB J Biol Chem; 1995 Nov; 270(46):27475-80. PubMed ID: 7499204 [TBL] [Abstract][Full Text] [Related]
11. In vivo reconstitution of highly active Candida maltosa cytochrome P450 monooxygenase systems in inducible membranes of Saccharomyces cerevisiae. Zimmer T; Kaminski K; Scheller U; Vogel F; Schunck WH DNA Cell Biol; 1995 Jul; 14(7):619-28. PubMed ID: 7626221 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a fusion protein between human cytochrome P450 1A1 and rat NADPH-P450 oxidoreductase in Escherichia coli. Chun YJ; Jeong TC; Roh JK; Guengerich FP Biochem Biophys Res Commun; 1997 Jan; 230(1):211-4. PubMed ID: 9020048 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Dong MS; Yamazaki H; Guo Z; Guengerich FP Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5. Inui H; Maeda A; Ohkawa H Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855 [TBL] [Abstract][Full Text] [Related]
15. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. Chun YJ; Shimada T; Guengerich FP Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703 [TBL] [Abstract][Full Text] [Related]
16. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase. Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864 [TBL] [Abstract][Full Text] [Related]
17. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification. Buters JT; Shou M; Hardwick JP; Korzekwa KR; Gonzalez FJ Drug Metab Dispos; 1995 Jul; 23(7):696-701. PubMed ID: 7587956 [TBL] [Abstract][Full Text] [Related]
18. Expression of CYP71B7, a cytochrome P450 expressed sequence Tag from Arabidopsis thaliana. Maughan JA; Nugent JH; Hallahan DL Arch Biochem Biophys; 1997 May; 341(1):104-11. PubMed ID: 9143359 [TBL] [Abstract][Full Text] [Related]
19. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae. Sakaki T; Shibata M; Yabusaki Y; Murakami H; Ohkawa H DNA Cell Biol; 1990 Oct; 9(8):603-14. PubMed ID: 2125425 [TBL] [Abstract][Full Text] [Related]